Business Wire

PA-BENTLEY-SYSTEMS

23.3.2021 15:04:01 CET | Business Wire | Press release

Share
Bentley Acceleration Initiatives Launches OpenTower iQ, a Digital Co-Venture with Visual Intelligence and Aeroprotechnik for 5G Towers

Bentley Acceleration Initiatives today announced the availability of OpenTower® iQ , a digital twin solution “powered by iTwin” for telecom towers that provides 3D visualization, real-time decision support, and predictive design from the ground up. OpenTower iQ is the result of a digital co-venture between Bentley and Visual Intelligence, a Houston, Texas-based sensor technology company, and Aeroprotechnik, an aerial inspection engineering company based in Viseu, Portugal.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210323005733/en/

Bentley Acceleration Initiatives is Bentley Systems’ (Nasdaq: BSY) strategic investment fund and incubator initiative. Its objective is to bring together ecosystem partners in a digital co-ventures to accelerate the go-to-market of creative cloud solutions based on the Bentley iTwin platform. OpenTower iQ , ‘powered by iTwin,’ is a textbook example of co-venturing that combines innovative digital technologies from entrepreneurial companies to address a market need in double-quick time.

As the demand for data continues to grow, tower companies and engineering firms are looking for all-inclusive, engineering-grade solutions to co-locate, modify, and maintain telecom infrastructure for the 5G rollout. OpenTower iQ makes it easy to modify existing towers and maintain accurate models, automating the repetitive work of producing as-built models and using artificial intelligence to detect critical components.

Tower companies can use OpenTower iQ to monitor the health of their towers and gain access to shared, secured data through an easy-to-understand portal. Data analytics provide cost benefit analysis to boost operational efficiency and revenue assurance. Improved accuracy of tower inspections and smart inventory management saves time, cost, and improves safety. OpenTower iQ is designed to handle the large asset portfolios of operators, easily processing and analyzing tens of thousands of towers.

Combines artificial intelligence and patented drone technologies

To accelerate the launch of OpenTower iQ , Bentley Acceleration Initiatives acquired digital twin technology from Aeroprotechnik, a leading aerial inspection engineering company that specializes in automated asset data capture and digitalization solutions. The technology included artificial intelligence and reality modeling capabilities that provide detailed information on current site conditions, which helps tower companies speed up rollouts, enhance decision-making, and shorten sales cycles.

Bentley Acceleration Initiatives also partnered with Visual Intelligence whose patented dual-sensor drone technology digitalizes physical infrastructure with millimeter accuracy to reliably deliver 3D, engineering-grade asset intelligence. Visual Intelligence is able to map more measurable surface area than alternative aerial and ground-based methods. Its patented drone sensor technology has the unique ability to capture the components of a tower including bolts, wires, ladders, and other items with an extremely high degree of accuracy that was not previously possible.

Now, with a comprehensive millimeter accurate digital twin, a tower company can virtually inspect their tower, see if it has been constructed correctly, determine if the tower’s structural integrity is intact, and run co-location scenarios. Unlike rudimentary reality models produced from other cameras, Visual Intelligence enables a digital twin with such accuracy that it can support advanced analyses such as connection integrity analysis and mount mapping analysis.

“The objective of Bentley Acceleration Initiatives is to incubate new businesses and augment existing ones using Bentley iTwin technologies. We provide a go-to-market accelerator to rapidly bring to users the innovative ideas from Bentley’s research and development in partnership with emerging industry leaders and technology specialists such as Visual Intelligence and Aeroprotechnik. Bentley Acceleration Initiatives helped incubate OpenTower iQ by funding its development, seeking out technology partnerships to fill whitespaces, and creating a comprehensive go-to-market strategy,” said Santanu Das, senior vice president, chief acceleration officer, Bentley Acceleration Initiatives. “Our next step is to invite additional interested ecosystem partners to kick start new digital integrator services to capture huge emerging opportunities for enterprise integration and implementation for towers. The telecom industry is going through a rapid transformation as multinetwork operators are expanding their portfolios through consolidation and moving from a 4G platform to 5G. Without a doubt, digital twin solutions like OpenTower iQ , ‘powered by iTwin,’ will help tower owners make the most of the industry’s burgeoning opportunities.”

OpenTower iQ for tower planning and management is a game changer for the telecom market. Within a couple of days, we had a high-quality reality model available with the reports and other aspects of the projects. Now, all the tower data is available in digital form—and it’s accurate and current,” said Nikhil Jani, vice president, telecom and utilities, Genesys International.

“Until now, drone data has failed to live up to its promise to the tower industry. This is largely because survey-grade drone sensors can’t collect the fidelity of data required to extract engineering-grade tower intelligence. Our patented drone sensor technology is the first of its kind to collect millimeter-class tower information. We partnered with Bentley to utilize OpenTower iQ to translate this new fidelity of data into as-built digital twins, and then apply AI to automate and unlock new kinds of tower insights. With OpenTower iQ , we’re enabling new applications of drone data and accelerating the value of digital twins to tower companies worldwide,” said Ted Miller, founder and chairman of Visual Intelligence and former chairman and CEO of Crown Castle International (NYSE: CCI).

“Bentley Acceleration Initiatives proved to be an effective platform for ecosystem partners like Aeroprotechnik to scale up artificial intelligence-based solutions, transforming emerging technologies into real value for Bentley’s users,” said Nuno Marques, founder of Aeroprotechnik.

Images and captions:

About Visual Intelligence

Visual Intelligence, based in Houston, Texas, has emerged as an industry-leading software and sensor technology company that delivers geo-imaging solutions for airborne, terrestrial, and mobile applications. It provides the Visual Intelligence unified drone sensor and software automation platform that digitizes physical infrastructure with millimeter accuracy to reliably deliver 3D, engineering-grade asset intelligence. https://visualintelligenceinc.com/telecom/

About Bentley Systems

Bentley Systems (Nasdaq: BSY) is the infrastructure engineering software company. We provide innovative software to advance the world’s infrastructure – sustaining both the global economy and environment. Our industry-leading software solutions are used by professionals, and organizations of every size, for the design, construction, and operations of roads and bridges, rail and transit, water and wastewater, public works and utilities, buildings and campuses, and industrial facilities. Our offerings include MicroStation -based applications for modeling and simulation, ProjectWise for project delivery, AssetWise for asset and network performance, and the iTwin platform for infrastructure digital twins. Bentley Systems employs more than 4,000 colleagues and generates annualized revenues of more than $800 million in 172 countries. www.bentley.com www.bentleyaccelerationinitiatives.com . www.opentower.com

© 2021 Bentley Systems, Incorporated. Bentley, the Bentley logo, AssetWise, iTwin, MicroStation, OpenTower, OpenTower iQ, and ProjectWise are either registered or unregistered trademarks or service marks of Bentley Systems, Incorporated or one of its direct or indirect wholly owned subsidiaries. All other brands and product names are trademarks of their respective owners.

Link:

ClickThru

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Galderma Receives U.S. FDA Approval for Differin® Epiduo® Acne Gel Prescription-to-OTC Switch22.5.2026 18:25:00 CEST | Press release

A unique Prescription-to-OTC switch in acne care, this approval expands access to a dermatologist-trusted, prescription-strength treatment for millions of acne sufferers ages 12 years and older Backed by more than 15 years of real-world dermatologist use and a robust clinical research program, this milestone demonstrates the depth of science behind the Differin® and Epiduo® heritage Adapalene plus benzoyl peroxide (0.1/2.5%) was the first FDA-approved, stable, fixed- dose prescription acne treatment to combine of benzoyl peroxide with a retinoid, and is now available over-the-counter The formulation is engineered to target multiple causes of acne more effectively than either of its individual active ingredients alone Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) us

Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia22.5.2026 16:18:00 CEST | Press release

Avanzanite will commercialise and distribute PYRUKYND in Europe under its exclusive agreement with Agios Avanzanite is committed to collaborating with local authorities in the EU to enable access to PYRUKYND for adult patients with thalassaemia Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner, Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts focused on delivering innovative medicines for patients with rare diseases, announced that the European Commission has granted marketing authorisation for PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, in adults for the treatment of anaemia associated with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassaemia, with an orphan medicinal product designation. This press release features multimedia. View the full releas

ICE Brent and ICE WTI Perpetual Futures to Launch on OKX22.5.2026 14:30:00 CEST | Press release

OKX, a blockchain technology and trading company serving more than 120 million customers globally,and Intercontinental Exchange (NYSE: ICE), one of the world's leading providers of financial market technology and data powering global capital markets including the New York Stock Exchange, today announced plans for OKX to launch perpetual futures based on ICE's Brent Crude and WTI Crude energy benchmarks. The products are expected to be available to trade on OKX’s platform in jurisdictions where OKX is licensed to offer perpetual futures products. The new OKX contracts represent a major step forward in expanding regulated access to global commodity markets through digital asset infrastructure. This first product collaboration between OKX and ICE comes after the companies established a strategic relationship in March 2026. ICE operates some of the world’s leading exchanges, clearing houses and market data services across energy, commodities, fixed income and equities markets. ICE’s future

Enhertu® Recommended for Approval in the EU by CHMP for Patients with Previously Treated HER2 Positive Metastatic Solid Tumors22.5.2026 14:00:00 CEST | Press release

Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the treatment of adult patients with unresectable or metastatic HER2 positive (immunohistochemistry [IHC] 3+) solid tumors who have received prior treatment and who have no satisfactory treatment options. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from patients with HER2 positive (IHC 3+) tumors in three phase 2 trials including DESTINY-PanTumor02,DESTINY-Lung01 andDESTINY-CRC02 where Enhertu demonstrated clinically meaningful responses across a broad range of tumors. The recommendation will now be reviewed by the European Commission, which has the authority

Future Health Challenge Awards USD 300,000 to Early Detection and Population Health Sensing Tools on Sidelines of World Health Assembly22.5.2026 13:45:00 CEST | Press release

Global teams recognised in the Future Health Challenge for solutions designed to detect health risks earlier and support faster health system decisions Future Health – A Global Initiative by Abu Dhabi and MIT Solve announce the winners of the inaugural Future Health ChallengeWinning solution equips frontline health workers in low-resource settings with mobile clinical decision-support tools, enabling earlier detection and more effective care deliveryTeams competed for a USD 200,000 grand prize and two USD 50,000 runner-up awards on the sidelines of the 79th World Health Assembly in GenevaWinners recognised for solutions advancing anticipatory, data-driven health systems Three global teams developing early detection and real-time population health monitoring solutions have secured a total of USD 300,000 on the sidelines of the 79th World Health Assembly. The winning solutions address critical challenges in early detection, continuous population insight and more timely decision making, s

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye